Nurse Practitioner, Family · Fort Wayne, IN
NPI
1790199255
Since 2014
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
7900 W Jefferson Blvd Ste 201
Fort Wayne, IN, 46804
Phone (260) 432-2297
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
1,203 services
Medicare patients, 2024
182
Average age 71
Drug cost, 2024
$2.6M
5,352 prescriptions
Company payments, 2025
$2,047
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julia A Ellingwood was code 99214 (office e&m - established), 422 times for 174 patients. In total Julia A Ellingwood billed 1,203 services in 9 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 422 | 174 | $68.19 | $29K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 338 | 166 | $10.06 | $3,399 |
| 95251 Test - Miscellaneous | Office | 230 | 101 | $19.47 | $4,477 |
| 83036 Blood Count | Office | 135 | 94 | $8.92 | $1,204 |
By year: 2022 $50K for 1,717 services; 2023 $46K for 1,420 services; 2024 $40K for 1,203 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 135 | 94 | $8.92 | $1,204 |
Medicare prescription drug claims, 2024
In 2024, the drug Julia A Ellingwood prescribed most often to Medicare patients was Levothyroxine Sodium, with 469 prescriptions and refills. In total Julia A Ellingwood wrote 5,352 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 469 | 1,242 | 120 | $4,194 |
| Ozempic Semaglutide | 321 | 513 | 67 | $489K |
| Jardiance Empagliflozin | 234 | 459 | 51 | $263K |
| Atorvastatin Calcium Generic | 231 | 564 | 60 | $1,907 |
| Metformin Hcl Generic | 219 | 601 | 66 | $1,346 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 203 | 482 | 63 | $52K |
| Mounjaro Tirzepatide | 203 | 226 | 37 | $242K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 186 | 398 | 48 | $226K |
| Humalog Kwikpen U-100 Insulin Lispro | 145 | 387 | 50 | $71K |
| Metformin Hcl Er Metformin Hcl | 135 | 389 | 42 | $1,466 |
| Trulicity Dulaglutide | 117 | 212 | 26 | $207K |
| Farxiga Dapagliflozin Propanediol | 109 | 210 | 23 | $117K |
| Gabapentin Generic | 105 | 228 | 25 | $2,024 |
| Novolog Flexpen Insulin Aspart | 101 | 250 | 41 | $39K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 90 | 195 | 33 | $10K |
Brand drugs: 2,808 claims; generic drugs: 1,967 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julia A Ellingwood $2,047 ($2,047 in general payments such as food, travel and fees) from 30 companies. The largest payer was Abbvie Inc. with $249.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $249 |
| Lilly USA, LLC LLY | 17 | $215 |
| Abbott Laboratories ABT | 13 | $194 |
| Medtronic, Inc. MDT | 9 | $165 |
| Beta Bionics, Inc. BBNX | 4 | $103 |
| Corcept Therapeutics CORT | 5 | $96.41 |
| Insulet Corporation PODD | 4 | $90.41 |
| Tandem Diabetes Care, Inc. TNDM | 6 | $86.55 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $75.41 |
| Dexcom, Inc. DXCM | 3 | $67.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.